Gilder Gagnon Howe & Co’s Twist Bioscience TWST Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-51,140	Closed	-$3.96M	–	351
2021 Q4	$3.96M	Buy	+51,140	New	+$5.25M	0.02%	234
2020 Q4	–	Sell	-12,808	Closed	-$973K	–	351
2020 Q3	$973K	Sell	12,808 -466	-4%	-$29K	0.01%	261
2020 Q2	$601K	Sell	13,274 -895	-6%	-$32.1K	﹤0.01%	250
2020 Q1	$433K	Sell	14,169 -209,507	-94%	-$5.63M	0.01%	222
2019 Q4	$4.7M	Sell	223,676 -52,819	-19%	-$1.24M	0.05%	172
2019 Q3	$6.6M	Sell	276,495 -2,646	-0.9%	-$76.9K	0.08%	146
2019 Q2	$8.1M	Buy	+279,141	New	+$7.38M	0.08%	138

Other funds holding TWST

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Gilder Gagnon Howe & Co's TWST Position: Q1 2022 in Review

Gilder Gagnon Howe & Co sold out of Twist Bioscience (TWST) in Q1 2022, closing a stake of 51,140 shares — an estimated $3.96M sold.

Gilder Gagnon Howe & Co first reported a position in TWST in Q2 2019 and held it in 7 quarters. The position peaked at $8.1M in Q2 2019. 212 funds tracked by Wall St. Rank hold TWST as of Q1 2022.

Gilder Gagnon Howe & Co reported no remaining Twist Bioscience position as of Q1 2022 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 51,140 Twist Bioscience shares in Q1 2022, an estimated $3.96M.
Gilder Gagnon Howe & Co first reported a position in Twist Bioscience in Q2 2019 and held it in 7 quarters.
Gilder Gagnon Howe & Co's Twist Bioscience position peaked at $8.1M in Q2 2019.
212 funds tracked by Wall St. Rank held Twist Bioscience as of Q1 2022.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2022, filed 16 May 2022.